FDA issues emergency authorisation for nCoV Real-Time RT-PCR diagnostic panel,a diagnostic test for coronavirus.
The FDA has issued emergency use authorisation (EUA) of a diagnostic test for the novel coronavirus, reported to infect more than 24,000 people and kill over 400 since emerging in China in December 2019.
Developed by the Centers for Disease Control and Prevention (CDC), the 2019-nCoV Real-Time RT-PCR diagnostic panel is a test that has previously been limited only to CDC laboratories.The latest authorisation from the FDA will enable to use of the test at any CDC-qualified lab across the country. The US Government recently declared a public health emergency even though the threat of the coronavirus in the US remains relatively low according to the federal health officials.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins